Free Trial

West Pharmaceutical Services (WST) Competitors

West Pharmaceutical Services logo
$210.72 +7.07 (+3.47%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$208.14 -2.58 (-1.22%)
As of 02/21/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WST vs. COO, ALGN, MMSI, ICUI, XRAY, HAE, QDEL, NEOG, STAA, and CERS

Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

West Pharmaceutical Services vs.

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.

West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies10.07% 9.38% 6.09%
West Pharmaceutical Services 17.03%18.60%13.80%

In the previous week, West Pharmaceutical Services had 5 more articles in the media than Cooper Companies. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 14 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.76 beat West Pharmaceutical Services' score of 0.36 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
10 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
6 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$3.90B4.53$392.30M$1.9545.37
West Pharmaceutical Services$2.89B5.27$492.70M$6.6931.50

Cooper Companies has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, West Pharmaceutical Services has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cooper Companies currently has a consensus price target of $117.00, indicating a potential upside of 32.23%. West Pharmaceutical Services has a consensus price target of $344.00, indicating a potential upside of 63.25%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.82
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Cooper Companies received 351 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.38% of users gave Cooper Companies an outperform vote while only 56.04% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
Cooper CompaniesOutperform Votes
620
66.38%
Underperform Votes
314
33.62%
West Pharmaceutical ServicesOutperform Votes
269
56.04%
Underperform Votes
211
43.96%

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WST vs. The Competition

MetricWest Pharmaceutical ServicesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$14.72B$4.59B$5.77B$20.07B
Dividend Yield0.41%39.91%4.78%3.65%
P/E Ratio31.5031.4526.4634.90
Price / Sales5.2750.79453.2515.64
Price / Cash22.4751.2344.0420.85
Price / Book5.686.577.634.92
Net Income$492.70M$90.13M$3.18B$1.02B
7 Day Performance-1.91%-2.20%-1.91%-1.05%
1 Month Performance-39.36%-2.17%-0.19%-1.09%
1 Year Performance-41.45%15.26%16.70%13.70%

West Pharmaceutical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WST
West Pharmaceutical Services
4.9557 of 5 stars
$210.72
+3.5%
$344.00
+63.2%
-40.8%$14.72B$2.89B31.5010,600Dividend Announcement
Analyst Downgrade
COO
Cooper Companies
2.7647 of 5 stars
$88.10
-6.0%
$117.00
+32.8%
-9.8%$17.58B$3.90B45.1816,000High Trading Volume
ALGN
Align Technology
4.7923 of 5 stars
$206.77
+0.9%
$269.91
+30.5%
-37.5%$15.44B$4.00B36.8621,610
MMSI
Merit Medical Systems
3.6393 of 5 stars
$108.14
-0.2%
$109.80
+1.5%
+30.1%$6.30B$1.26B53.016,950Positive News
ICUI
ICU Medical
4.6739 of 5 stars
$160.16
+1.2%
$199.67
+24.7%
+51.1%$3.92B$2.26B-35.0514,000News Coverage
XRAY
DENTSPLY SIRONA
4.8631 of 5 stars
$18.32
-2.4%
$25.85
+41.1%
-43.3%$3.64B$3.97B-8.8515,000Analyst Upgrade
HAE
Haemonetics
4.6234 of 5 stars
$62.47
+0.3%
$101.67
+62.8%
-14.0%$3.14B$1.31B24.593,657Analyst Revision
QDEL
QuidelOrtho
4.7933 of 5 stars
$40.57
-2.6%
$51.20
+26.2%
-18.2%$2.73B$3.00B-1.457,100
NEOG
Neogen
3.7181 of 5 stars
$9.83
-0.9%
$14.00
+42.4%
-41.5%$2.13B$924.22M-4.492,110
STAA
STAAR Surgical
4.367 of 5 stars
$15.35
-3.8%
$26.86
+75.0%
-44.5%$756.45M$322.42M34.891,115High Trading Volume
CERS
Cerus
2.8671 of 5 stars
$1.85
+2.8%
$3.63
+95.9%
-26.3%$343.57M$176.23M-16.82290Earnings Report
Analyst Forecast
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:WST) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners